title: Parkinson's disease.
abstract: Parkinson's disease is one of the most common neurodegenerative diseases caused by degeneration of dopaminergic neurons in substantia nigra. The neuropathologic hallmark of Parkinson's disease is the presence of Lewy bodies composed mostly of alpha-synuclein and ubiquitin. It is believed that the occurrence of Parkinson's disease is due to a combination of genetic and environmental factors, but the exact mechanism of Parkinson's disease development is not fully elucidated. The most characteristic motor symptoms for Parkinson's disease include bradykinesia, rigidity, resting tremor and postural instability, while many patients also have non-motor signs and symptoms. The key therapeutic agent in the treatment of Parkinson's disease is L-dopa, and the others are dopaminergic agents, monoamine oxidase-B (MAO-B) inhibitors, catechol-O-methyltransferase (COMT) inhibitors, amantadine and anticholinergic agents.
authors.affiliation: University Department of Neurology, Reference Center for Neurovascular Disorders, Ministry of Health and Social Welfare, Republic of Croatia, Sestre milosrdnice University Hospital, Zagreb, Croatia. Raphaelbene.hr@gmail.com
authors.forename: Raphael
authors.initials: R
authors.lastname: Béné
authors.forename: Sonja
authors.initials: S
authors.lastname: Antić
authors.forename: Mislav
authors.initials: M
authors.lastname: Budisić
authors.forename: Marijana
authors.initials: M
authors.lastname: Lisak
authors.forename: Zlatko
authors.initials: Z
authors.lastname: Trkanjec
authors.forename: Vida
authors.initials: V
authors.lastname: Demarin
authors.forename: Slava
authors.initials: S
authors.lastname: Podobnik-Sarkanji
mesh_terms: D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy